Consolidated Investment Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Hold
21,000
0.19% 69
2026
Q1
$1.51M Buy
+21,000
New +$1.62M 0.16% 72
2024
Q1
Sell
-11,500
Closed -$908K 63
2023
Q4
$908K Sell
11,500
-52,500
-82% -$3.74M 0.16% 59
2023
Q3
$4.47M Hold
64,000
0.86% 32
2023
Q2
$4.42M Hold
64,000
0.79% 33
2023
Q1
$4.76M Buy
64,000
+7,000
+12% +$587K 0.93% 28
2022
Q4
$5.31M Buy
57,000
+8,500
+18% +$820K 1.14% 24
2022
Q3
$4.63M Buy
48,500
+2,500
+5% +$247K 1% 26
2022
Q2
$4.26M Buy
46,000
+2,500
+6% +$244K 0.81% 35
2022
Q1
$4.4M Buy
43,500
+36,500
+521% +$3.83M 0.72% 39
2021
Q4
$722K Buy
+7,000
New +$647K 0.11% 70

Other funds holding CVS

Consolidated Investment Group's CVS Position: Q2 2026 in Review

Consolidated Investment Group held its CVS Health (CVS) position steady in Q2 2026 at 21,000 shares worth $2.17M. The position accounts for 0.19% of the portfolio, ranked #69.

Consolidated Investment Group first reported a position in CVS in Q4 2021 and has held it in 11 quarters since. The position peaked at $5.31M in Q4 2022. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Consolidated Investment Group held 21,000 shares of CVS Health worth $2.17M as of Q2 2026.
  • Consolidated Investment Group left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.19% of Consolidated Investment Group's portfolio in Q2 2026, its #69 holding.
  • Consolidated Investment Group first reported a position in CVS Health in Q4 2021 and has held it in 11 quarters since.
  • Consolidated Investment Group's CVS Health position peaked at $5.31M in Q4 2022.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Consolidated Investment Group's 13F filing for Q2 2026, filed 22 Jul 2026.